BNP Paribas Financial Markets’s Bioverativ Inc. Common Stock BIVV Stock Holding History

BNP Paribas Financial Markets’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-111,665	Closed	-$6.02M	–	4420
2017 Q4	$6.02M	Sell	111,665 -269,058	-71%	-$14.7M	0.01%	951
2017 Q3	$21.7M	Buy	380,723 +31,841	+9%	+$1.86M	0.05%	321
2017 Q2	$21M	Buy	348,882 +244,116	+233%	+$13.9M	0.06%	301
2017 Q1	$5.71M	Buy	+104,766	New	+$5.16M	0.02%	743

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

BNP Paribas Financial Markets's BIVV Position: Q1 2018 in Review

BNP Paribas Financial Markets sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 111,665 shares — an estimated $6.02M sold.

BNP Paribas Financial Markets first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $21.7M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

BNP Paribas Financial Markets reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
BNP Paribas Financial Markets sold 111,665 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $6.02M.
BNP Paribas Financial Markets first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
BNP Paribas Financial Markets's Bioverativ Inc. Common Stock position peaked at $21.7M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2018, filed 11 May 2018.